References
- Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015 Sep;46(3):622–639.
- Zhu X, Wei Y, Dong J. Long noncoding RNAs in the regulation of asthma: current research and clinical implications. Front Pharmacol. 2020 Sep 11;11:532849.
- Thompson EE, Dang Q, Mitchell-Handley B, et al. Cytokine-induced molecular responses in airway smooth muscle cells inform genome-wide association studies of asthma. Genome Med. 2020 Jul 20;12(1):64.
- Shi ZG, Sun Y, Wang KS, et al. Effects of miR-26a/miR-146a/miR-31 on airway inflammation of asthma mice and asthma children. Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5432–5440.
- Sun M, Huang Y, Li F, et al. MicroRNA-874 inhibits TNF-α-induced remodeling in human fetal airway smooth muscle cells by targeting STAT3. Respir Physiol Neurobiol. 2018 May;251:34–40.
- PZhu MX, Huang LH, Zhu YK, et al. LncRNA NEAT1 promotes airway smooth muscle cell inflammation by activating the JAK3/STAT5 pathway through targeting of miR-139. Exp Lung Res. 2021 Feb;16:1–13.
- Wang G, Yu X, Xia J, et al. MicroRNA-9 restrains the sharp increase and boost apoptosis of human acute myeloid leukemia cells by adjusting the Hippo/YAP signaling pathway. Bioengineered. 2021 Dec;12(1):2906–2914.
- Yu L, Sun Y, Chu Z. MiR-212-3p promotes proliferation and migration of trophoblast in fetal growth restriction by targeting placental growth factor. Bioengineered. 2021 Dec;12(1):5655–5663.
- Perry MM, Baker JE, Gibeon DS, et al. Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma. Am J Respir Cell Mol Biol. 2014 Jan;50(1):7–17.
- Chiba Y, Misawa M. MicroRNAs and their therapeutic potential for human diseases: miR-133a and bronchial smooth muscle hyperresponsiveness in asthma. J Pharmacol Sci. 2010;114(3):264–268.
- Zhao L, Shi X, Wang N, et al. YAP1, targeted by miR-375, enhanced the pro-angiogenesis of airway smooth muscle cells in asthma via STAT3 activation. Cell Cycle. 2020 Jun;19(11):1275–1284.
- Bartel S, Carraro G, Alessandrini F, et al. miR-142-3p is associated with aberrant WNT signaling during airway remodeling in asthma. Am J Physiol Lung Cell Mol Physiol. 2018 Aug 1;315(2):L328–L333.
- Dong L, Wang Y, Zheng T, et al. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice. Stem Cell Res Ther. 2021 Jan 6;12(1):4.
- Lou L, Tian M, Chang J, et al. MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7. Biomed Pharmacother. 2020 Feb;122:109692.
- Hirai K, Shirai T, Shimoshikiryo T, et al. Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap. Allergy. 2021 Mar;76(3):766–774.
- Hong AW, Meng Z, Guan KL. The Hippo pathway in intestinal regeneration and disease. Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):324–337.
- Dong T, Sun X, and Jin H. Role of YAP1 gene in proliferation, osteogenic differentiation, and apoptosis of human periodontal ligament stem cells induced by TNF-α. J Periodontol. 2021 Aug;92(8): 1192-1200.
- Fu J, Zheng M, Zhang X, et al. Fibulin-5 promotes airway smooth muscle cell proliferation and migration via modulating Hippo-YAP/TAZ pathway. Biochem Biophys Res Commun. 2017 Nov 18;493(2):985–991.
- Jude JA, Dileepan M, Subramanian S, et al. miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2012 Sep;303(5):L460–8.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402–408.
- Cheng X, Zhao L, Ke T, et al. Celecoxib ameliorates diabetic neuropathy by decreasing apoptosis and oxidative stress in dorsal root ganglion neurons via the miR-155/COX-2 axis. Exp Ther Med. 2021 Aug;22(2):825.
- Liu G, Cooley MA, Nair PM, et al. Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c. J Pathol. 2017 Dec;243(4):510–523.
- Lin J, Feng X, Zhang J, et al. Long noncoding RNA TUG1 promotes airway smooth muscle cells proliferation and migration via sponging miR-590-5p/FGF1 in asthma. Am J Transl Res. 2019 May 15;11(5):3159–3166.
- Kong Y, Ding L, Xu Y, et al. YiQi GuBen formula inhibits PDGF-BB-induced proliferation and migration of airway smooth muscle cells. Pharmacology. 2020;105(7–8):424–433.
- Gao Y, Wang B, Luo H, et al. miR-217 represses TGF-β1-induced airway smooth muscle cell proliferation and migration through targeting ZEB1. Biomed Pharmacother. 2018 Dec;108:27–35.
- Zhang L, Zhang X, Zheng J, et al. Depressive symptom-associated IL-1β and TNF-α release correlates with impaired bronchodilator response and neutrophilic airway inflammation in asthma. Clin Exp Allergy. 2019 Jun;49(6):770–780.
- Alrashdan YA, Alkhouri H, Chen E, et al. Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L1118–27.
- Dang X, He B, Ning Q, et al. Suppression of TRIM8 by microRNA-182-5p restricts tumor necrosis factor-α-induced proliferation and migration of airway smooth muscle cells through inactivation of NF-Κb. Int Immunopharmacol. 2020 Jun;83:106475.
- Wu Y, Zou F, Lu Y, et al. SETD7 promotes TNF-α-induced proliferation and migration of airway smooth muscle cells in vitro through enhancing NF-κB/CD38 signaling. Int Immunopharmacol. 2019 Jul;72:459–466.
- Wang H, Yao H, Yi B, et al. MicroRNA-638 inhibits human airway smooth muscle cell proliferation and migration through targeting cyclin D1 and NOR1. J Cell Physiol. 2018 Jan;234(1):369–381.
- Zhang H, Yan HL, Li XY, et al. TNFSF14, a novel target of miR-326, facilitates airway remodeling in airway smooth muscle cells via inducing extracellular matrix protein deposition and proliferation. Kaohsiung J Med Sci. 2020 Jul;36(7):508–514.
- Dong Y, Zhang N, Zhao S, et al. miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer. Oncol Lett. 2019 Dec;18(6):6491–6500.
- Wu B, Liu G, Jin Y, et al. miR-15b-5p promotes growth and metastasis in breast cancer by targeting HPSE2. Front Oncol. 2020 Feb 26;10:108.
- Guo K, Qi D, Huang B. LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis. Cancer Cell Int. 2021 Feb 1;21(1):84.
- Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010 Oct 19;19(4):491–505.
- Yamamoto M, Ohsawa S, Kunimasa K, et al. The ligand Sas and its receptor PTP10D drive tumour-suppressive cell competition. Nature. 2017 Feb 9;542(7640):246–250.
- Xiao Y, Zhang H, Ma Q, et al. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation. Cancer Lett. 2019 Oct 10;462:51–60.
- Sun Z, Ou C, Liu J, et al. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2019 Apr;38(14):2627–2644.
- Xu M, Gu M, Zhou J, et al. Interaction of YAP1 and mTOR promotes bladder cancer progression. Int J Oncol. 2020 Jan;56(1):232–242.
- Fodor LE, Gézsi A, Ungvári L, et al. Investigation of the possible role of the Hippo/YAP1 pathway in asthma and allergy. Allergy Asthma Immunol Res. 2017 May;9(3):247–256.
- Zhou J, Xu F, Yu JJ, et al. YAP is up-regulated in the bronchial airway smooth muscle of the chronic asthma mouse model. Int J Clin Exp Pathol. 2015 Sep 1;8(9):11132–11139.
- He J, Su X, Xie W. MiR-582-3p alleviates osteoarthritis progression by targeting YAP1. Mol Immunol. 2020 Dec;128:258–267.
- Miao W, Li N, Gu B, et al. MiR-27b-3p suppresses glioma development via targeting YAP1. Biochem Cell Biol. 2020 Aug;98(4):466–473.